| 產品規(guī)格 |
10 mg, 25 mg, 100 mg, 200 mg, 250 mg, 500 mg, 1 g, 2 g, 50 mg |
| 產品詳情 |
| Edit |   |
|---|
| Product Name | Ponatinib, Free Base |
|---|
| Description | Ponatinib, Free Base. Ponatinib is also known as AP24534, is a multi-targeted tyrosine kinase inhibitor and is active against T315I and other BCR-ABL mutants. Ponatinib inhibited native BCR-ABL (IC50=0.37 nM) and the mutants with IC50 values of 2 nM (T315I); 0.44 nM (Q252H); 0.3 nM (Y253F); 0.3 nM (M351T); and 0.34nM (H396P) in biochemical assays. It also inhibited the growth of Ba/F3 cells with IC50 values of 0.5 nM (Native BCR-ABL), 11 nM (T315I), 2.2 nM (Q252H), 2.8 nM (Y253F), 1.5 nM (M351T), and 1.1 nM (H396P). It suppressed BCR-ABL(T315I)-driven tumor growth in mice and completely overcame resistance in cell-based mutagenesis screens. MW: 532.56 g/mol. Purity >99% pure |
|---|
| Size | 10 mg, 25 mg, 100 mg, 200 mg, 250 mg, 500 mg, 1 g, 2 g, 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Iclusig, AP24534, AP-24534, Ponatinib, AP 24534 |
|---|
| Gene, Accession, CAS # | CAS: 943319-70-8 |
|---|
| Catalog # | orb153625 |
|---|
| Price | |
|---|
| Order / More Info | Ponatinib, Free Base from BIORBYT LTD. |
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|